secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sunshine Biopharma Inc. (SBFM)
CIK:        0001402328
Form:       8-K
Filed at:   2024-07-01T23:59:59+00:00
Accession:  0001683168-24-004572
Event type: regulatory
Sentiment:  neutral
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Sunshine Biopharma gets Nasdaq bid-price extension to Aug 26, 2024
------------------------------------------------------------------

- Received Nasdaq Hearings Panel exception until August 26, 2024 to regain minimum bid price compliance.
- Must achieve closing bid price of at least $1.00 for 10 consecutive business days by deadline.
- Company was previously notified of deficiency under Listing Rule 5550(a)(2).
- Failure to meet conditions may result in delisting from Nasdaq.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/0001683168-24-004572-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1402328/000168316824004572/sunshine_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-004572

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer